What factors help or stop teens with Type 1 diabetes from being physically active in Istanbul

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with Type 1 diabetes who meet inclusion criteria will complete standardized questionnaires about their physical activity, social participation, diabetes self-management, and relevant individual and environmental influences framed by the Socio-Ecological Model. Data collection focuses on multilevel domains: individual, interpersonal, institutional (school), community, and policy factors, together with reported glucose biomarkers and recent HbA1c. The study is observational and based at Biruni University in Zeytinburnu, recruiting school-attending adolescents using at least one glucose monitoring device and with HbA1c ≥ 8% within the past year. Analyses will identify modifiable barriers and facilitators associated with higher or lower levels of physical activity and related outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with Type 1 diabetes at least 1 year prior to enrollment,
* Aged between 9 and 18 years,
* Currently attending school in Istanbul,
* Willing to participate in the study (with voluntary consent),
* HbA1c value ≥ 8% within the past year,
* Reported glucose metabolism biomarkers,
* Sufficient cognitive ability to understand and complete the questionnaires,
* Under regular medical follow-up and using at least one glucose monitoring device.

Exclusion Criteria:

* Lack of parental consent,
* Presence of additional neurological, motor, or cognitive disorders,
* Inadequate mental status or diagnosis of moderate to severe intellectual disability,
* Presence of systemic comorbid diseases,
* Failure to report HbA1c data.

Where it's running

• Biruni University
  Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Buket Akinci, Professor
• Email: barbuket@hotmail.com
• Phone: +905056415692

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• VV-14300: a gene therapy approach for adults with type 1 diabetes not well controlled on an automated insulin system

  This trial tests VV-14300 in adults with type 1 diabetes who aren’t reaching their blood sugar goals despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Toronto and 1 other locations · NCT07831798

• New gene therapies VV-14299 and VV-14300 for adults with Type 1 Diabetes failing automated insulin delivery

  This study tests VV-14299 and VV-14300, or VV-14300 alone, in adults with long-standing Type 1 Diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Melbourne · NCT07829302

• Oral verapamil in newly diagnosed children and teens with type 1 diabetes

  This study tests whether taking verapamil by mouth can help preserve pancreatic beta cells and reduce insulin needs in kids and teens with recently diagnosed type 1 diabetes.

  Recruiting Phase 2/3 Ain Shams University · Cairo · NCT07804849

• Preventing device-related skin rashes in kids with type 1 diabetes using hydrocolloid vs silicone patches

  This study tests whether silicone-based or hydrocolloid patches help prevent recurring skin irritation from insulin pumps or CGMs in children and teens with type 1 diabetes.

  Recruiting Steno Diabetes Center Copenhagen · Copenhagen · NCT07767461

• AI-assisted remote insulin pump optimization for people with type 1 diabetes

  This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07732777

• Near-sensor insulin delivery with CGM in people with type 1 diabetes

  A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.

  Recruiting Early Phase 1 ClinSurge Research · Toronto, Ontario · NCT07655076

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.